TABLE 3.
Presence of Artifact | Clinical | MTC‐BOOST | P value |
---|---|---|---|
LM (R1) | 4.1 ± 1.0 | 3.3 ± 0.7 | <0.05 |
LM (R2) | 3.7 ± 1.5 | 4.0 ± 1.0 | 0.5 |
RCA (R1) | 4 ± 1.2 | 2.9 ± 1.1 | <0.05 |
RCA (R2) | 3.9 ± 1.4 | 2.7 ± 1.3 | <0.05 |
Aorta (R1) | 4.7 ± 0.6 | 4.2 ± 0.5 | <0.05 |
Aorta (R2) | 4.3 ± 1.0 | 3.7 ± 0.7 | <0.05 |
MPA (R1) | 4.2 ± 0.9 | 4.2 ± 0.8 | 0.9 |
MPA (R2) | 3.8 ± −1.4 | 3.8 ± 0.8 | 0.7 |
RPV (R1) | 3.3 ± 0.8 | 4.0 ± 0.7 | <0.05 |
RPV (R2) | 1.6 ± 0.6 | 3.3 ± 0.8 | <0.05 |
LPV (R1) | 3.1 ± 0.6 | 4.1 ± 0.6 | <0.05 |
LPV (R2) | 1.7 ± 0.7 | 4.0 ± 1.0 | <0.05 |
Image quality scores—presence of artifact. LM = left main coronary artery; RCA = right coronary artery; MPA = main pulmonary artery; RPV = right‐sided pulmonary veins; LPV = left‐sided pulmonary veins. Two blinded reviewers (R1, R2) assessed the clinical sequence (T2 prepared 3D whole heart) and MTC‐BOOST bright blood datasets to grade presence of artifact (1 = severe artifact, 2 = significant artifact, 3 = moderate artifact, 4 = mild artifact, and 5 = minimal artifact) where grades 1 and 2 delineate nondiagnostic datasets. For each observer, the scores were compared using a paired Wilcoxon signed‐rank test, with statistical significance difference set to P < 0.05.